Phibro Animal Health (PAHC) Misses Q3 EPS by 4c, FY Guidance Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corporation Reports Third Quarter Results
May 6, 2019 4:20 PM EDTTEANECK, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2019.
Highlights for the March 2019 quarter (compared to the March 2018 quarter)
Net sales of $206 million, a decrease of $3 million, or 2%Net income of $15 million, a decrease of $5 millionDiluted EPS of $0.37, a decrease of $0.12Adjusted EBITDA of $30 million, a decrease of $3.4 million, or 10%Adjusted diluted EPS of $0.39, a decrease of $0.07, or 15%Phibro also updated its full year financial guidance, to include:
... More